Abstract
Introduction: Drug development has a great deal to gain from the therapeutic and
preventative actions of medicinal plants and their derivatives. In order to introduce active medicinal
herbs and phytochemicals against viral infections of the respiratory system, we tried to focus
on a vast amount of data.
Methods: From 2000 to the present, articles from Web of Science, Scopus, ScienceDirect, Pub-
Med, and Google Scholar were taken into consideration. A combination of respiratory viral infection
with keywords of medicinal plants, phytochemicals, flavonoids, saponins, phenolics, terpenoids,
alkaloids, and natural products has been used, as well as keywords of antiviral medicinal
plants, and antiviral phytochemicals. Pure antiviral compounds and plants with activity against
viruses other than respiratory viruses were disregarded and excluded from consideration.
Results: More than eighty phytochemicals and sixty herbs that were subjected to in vitro and in
vivo investigations were documented. The current study collects information on multiple medicinal
plants, including Camellia sinensis, Sambucus nigra, Pelargonium sidoides, Echinacea purpurea,
and Glycyrrhiza glabra, which have been shown to have effective antiviral properties
through experimental research. The main antiviral phytochemicals were terpenoids, alkaloids,
and flavonoids. Additionally, chemicals including resveratrol, quercetin, chlorogenic acid, amentoflavone
A, biochanin, and glycyrrhizin demonstrated efficacy against many viral infections.
Conclusion: For the management of viral infections, the current review on the development of
novel antiviral medications is strongly advised. It also provides a possibility to discover anti-
COVID-19 lead compounds and can offer supportive treatment in this pandemic situation.
Keywords:
Respiratory viral, infection, medicinal plant, phytochemicals, mechanism, drug development.
[5]
Dasaraju, P.V.; Liu, C. Infections of the respiratory system, Medical Microbiology, 4th ed; University of Texas Medical Branch at Galveston: Galveston, USA, 1996.
[28]
Vimalanathan, S.; Schoop, R.; Hudson, J. High-potency anti-influenza therapy by a combination of Echinacea purpurea fresh herb and root tinctures. J. Appl. Pharm. Sci., 2013, 3(12), 001-005.
[57]
Lee, S.M.Y.; Du, G-H. In vitro anti-influenza viral activities of constituents from Caesalpinia sappan. Planta, 2009, 75(4), 337-339.
[65]
Grienke, U.; Braun, H.; Seidel, N.; Kirchmair, J.; Richter, M.; Krumbholz, A.; von Grafenstein, S.; Liedl, K.R.; Schmidtke, M.; Rollinger, J.M. Computer-guided approach to access the anti-influenza activity of licorice constituents. J Nat Prod, 2014, 77(3), 563-570.
[76]
Zhang, X.; He, J.; Huang, W.; Huang, H.; Zhang, Z.; Wang, J.; Yang, L.; Wang, G.; Wang, Y.; Li, Y. Antiviral activity of the sesquiterpene lactones from centipeda minima against influenza a virus in vitro. Natural Product Communications, 2018, 13(2), 115-119.
[100]
Payne, S. Family coronaviridae. Viruses, 2017, 149-158. PMCID = PMC 7149805.
[106]
Ren, S.Y.; Wang, W.B.; Hao, Y.G.; Zhang, H.R.; Wang, Z.C.; Chen, Y.L.; Gao, R.D. WJCC. WORLD, 2020, 8(4), 652-657.
[123]
Zhuang, M.; Jiang, H.; Suzuki, Y.; Li, X.; Xiao, P.; Tanaka, T.; Ling, H.; Yang, B.; Saitoh, H.; Zhang, L. Procyanidins and butanol extract of cinnamomi cortex inhibit SARS-CoV infection. Antiviral Res, 2009, 82(1), 73-81.
[143]
Kirchmair, A.; Liedl, R.; Rollinger, M.; Spitzer, M. Development of anti-viral agents using molecular modeling and virtual screening techniques. Infect Disord Drug Targets, 2020, 11(1), 64-93.
[152]
Zhang, L.; Li, F.; Wei, Y.; He, J.; Chen, H.; Hu, T.; Liao, L. Effects of Sophora subprostrate polysaccharide on cell viabilities and inflammatory cytokines of RAW264. 7 cells infected with porcine reproductive and respiratory syndrome virus (PRRSV). Nanfang Nongye Xuebao, 2016, 47(12), 2151-2156.
[154]
Chi, T-T. Bamboo extract for acute and chronic respiratory conditions, nutritional perspectives. J. Council Nutrition, 2014, 37, 5-13.
[162]
Tj, L.; Kc, W.; Cc, L.; Lc, C.; Js, C. Anti-viral activity of water extract of Paeonia lactiflora pallas against human respiratory syncytial virus in human respiratory tract cell. Am. J. Chin. Med., 2013, 41(3), 585-99.